Investors & Media

What's new.

Press releases

Press releases.

Results of EGM

July 26th 2021
press releases

Completion of Share Purchase Plan

July 21st 2021
press releases

Immutep Quarterly Activities Report & Appendix 4C

July 13th 2021
press releases

Investor updates

Investor updates.

Investor Update - April 2021

April 14th 2021
investor updates

Investor Update - August 2020

August 17th 2020
investor updates

Investor Update - November 2019

November 22nd 2019
investor updates

Analyst reports

Analyst reports.

Maxim Group - Unlocking the Synergistic Benefits of Efti (LAG-3), the Next Checkpoint - Transferring Coverage with a Buy Rating and $8 TP

July 16th 2021
analyst reports

Bell Potter - Creating Value with Phase 3 around the corner – Increasing TP to AUD 1.00 (from AUD 0.85)

July 14th 2021
analyst reports

goetzpartners securities -LAG-3 therapies taking immunology to the next level - Increasing TP to AUD 1.35 (from AUD 1.24)

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

July 6th 2021
analyst reports